Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 20 articles: HTML format

Single Articles

December 2020
1. SU H, Ye X, Freed DC, Li L, et al
   A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus.
   Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02422.
   PubMed     Abstract available
   
   
   October 2020
2. HAMILTON ST, Marschall M, Rawlinson WD
   Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy.
   Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01627.
   PubMed     Abstract available
   
   
   July 2020
3. MERCORELLI B, Luganini A, Celegato M, Palu G, et al
   The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.
   Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.00056.
   PubMed     Abstract available
   
   
   February 2020
4. ZARROUK K, Pham VD, Piret J, Shi R, et al
   Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
   Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.01910.
   PubMed     Abstract available
   
   
   
5. MAERTENS J, Logan AC, Jang J, Long G, et al
   Anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation: a phase 2 study.
   Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02467.
   PubMed     Abstract available
   
   
   May 2019
6. TURNER NA, Wolfe CR
   Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases".
   Antimicrob Agents Chemother. 2019;63.
   PubMed    
   
   
   
7. FRANGE P, Leruez-Ville M
   Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.
   Antimicrob Agents Chemother. 2019;63.
   PubMed    
   
   
   March 2019
8. RITCHIE BM, Barreto JN, Barreto EF, Crow SA, et al
   Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety.
   Antimicrob Agents Chemother. 2019;63.
   PubMed     Abstract available
   
   
   January 2019
9. TURNER N, Strand A, Grewal DS, Cox G, et al
   Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series.
   Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02337.
   PubMed     Abstract available
   
   
   October 2018
10. WANG Y, Mukhopadhyay R, Roy S, Kapoor A, et al
    Inhibition of Cytomegalovirus Replication with Extended Half-Life Synthetic Ozonides.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01735.
    PubMed     Abstract available
    
    
    June 2018
11. CHOU S, Satterwhite LE, Ercolani RJ
    A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00922.
    PubMed     Abstract available
    
    
    April 2018
12. OIKNINE-DJIAN E, Weisblum Y, Panet A, Wong HN, et al
    The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00288.
    PubMed     Abstract available
    
    
    March 2018
13. DONG Q, Leroux S, Shi HY, Xu HY, et al
    Model-based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection: A Pilot Study.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.00075.
    PubMed     Abstract available
    
    
    November 2017
14. DENG R, Wang Y, Maia M, Burgess T, et al
    Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01108.
    PubMed     Abstract available
    
    
    October 2017
15. MENG W, Tang A, Ye X, Gui X, et al
    Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01719.
    PubMed     Abstract available
    
    
    August 2017
16. CHOU S
    Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01325.
    PubMed     Abstract available
    
    
    
17. PIRET J, Goyette N, Boivin G
    Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01044.
    PubMed     Abstract available
    
    
    November 2016
18. ISHIDA JH, Patel A, Mehta AK, Gatault P, et al
    Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01794.
    PubMed     Abstract available
    
    
    April 2016
19. PADULLES A, Colom H, Bestard O, Melilli E, et al
    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.
    Antimicrob Agents Chemother. 2016;60:1992-2002.
    PubMed     Abstract available
    
    
    November 2015
20. VAZQUEZ JA, Manavathu EK
    Molecular Characterization of a Voriconazole-resistant, Posaconazole-susceptible, Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.01130.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: